+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
ID06146231

Study of Motiva Flora Tissue Expander and Ergonomix2 Breast Implants for Hybrid Breast Reconstruction in Adult Women

Led by Establishment Labs · Updated on 2025-11-26

66

Participants Needed

4

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

This research investigates a hybrid approach to breast reconstruction using the Motiva Flora Tissue Expander followed by serial fat grafting and the placement of a permanent Ergonomix2 breast implant. It aims to support the creation of an autologous adipose matrix to enhance breast reconstruction outcomes. The study is sponsored by Establishment Labs and focuses on women needing breast reconstruction due to conditions like breast cancer, Poland syndrome, or mammaplasty. Participants receive an initial skin expansion with the Motiva Flora Tissue Expander, which is gradually deflated during serial fat grafting procedures. Once the reverse expansion is complete, the expander is replaced with a long-term Ergonomix2 silicone breast implant. The study follows standard surgical care practices while evaluating this hybrid method. During the trial, participants will be closely monitored for a total adverse event rate over 46 months. Researchers will assess surgeon satisfaction, patient anxiety, depression, satisfaction, quality of life, device performance, breast volume changes, and vascularity. Follow-up includes imaging and clinical evaluations to ensure safety and effectiveness throughout the study period.

CONDITIONS

Brief Title

Motiva Flora® Aesthetic Breast Recon® Clinical Study

Research Team

L

Lilián Patricia Palma López

L

Laura García Jimenez

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here